Results 151 to 160 of about 2,431,785 (301)

A real option analysis for stochastic disease control and vaccine stockpile policy: An application to H1N1 in Korea. [PDF]

Econ Model, 2016
Park H.
europepmc   +1 more source

Valuing Joint Ventures Using Real Options [PDF]

As the valuation of strategic measures becomes increasingly important, relatively few articles have discussed the valuation methods pertained for joint ventures.
Stephan Schmidt-Tank, Ulrich Pape
core  

PARP inhibition and pharmacological ascorbate demonstrate synergy in castration‐resistant prostate cancer

Molecular Oncology, EarlyView.
Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon, Peter T. Gallagher, Orly I. Richter, Neermala Poudel Neupane, Amy C. Mandigo, Jennifer J. McCann, Emanuela Dylgjeri, Irina Vasilevskaya, Christopher McNair, Channing J. Paller, Wm. Kevin Kelly, Karen E. Knudsen, Matthew J. Schiewer, Ayesha A. Shafi   +13 more
wiley   +1 more source

A systematic review of the applications of the real option value of medical technologies in oncology. [PDF]

J Manag Care Spec Pharm
Adjei K, Diaby V, Li M, Sherbeny F, Suther S, Ali AA.   +5 more
europepmc   +1 more source

Evaluating architectural stability with real option theory [PDF]

, 2004
Bahsoon, R, Emmerich, W
core  

Irreversibility, endogenous mean reversion, and the investment decision of a foreign firm [PDF]

The paper derives a valuation formula for the real option of a firm to undertake an irreversible investment in a foreign economy based on the endogenous dynamics of a stochastic macroeconomic framework with sluggish price adjustment. The option valuation
Pierdzioch, Christian
core  

LDAcoop: Integrating non‐linear population dynamics into the analysis of clonogenic growth in vitro

Molecular Oncology, EarlyView.
Limiting dilution assays (LDAs) quantify clonogenic growth by seeding serial dilutions of cells and scoring wells for colony formation. The fraction of negative wells is plotted against cells seeded and analyzed using the non‐linear modeling of LDAcoop.
Nikko Brix, Daniel Samaga, Katharina Gehr, Benedek Dankó, Mohamed Schumann, Guido Drexler, Ahmed Alnatsha, Georg Beyer, Ujjwal Mahajan, Martin Selmansberger, Julia Mayerle, Claus Belka, Horst Zitzelsberger, Kirsten Lauber   +13 more
wiley   +1 more source

Will adaptive deep brain stimulation for Parkinson's disease become a real option soon? A Delphi consensus study. [PDF]

NPJ Parkinsons Dis
Guidetti M, Bocci T, De Pedro Del Álamo M, Deuschl G, Fasano A, Martinez-Fernandez R, Gasca-Salas C, Hamani C, Krauss JK, Kühn AA, Limousin P, Little S, Lozano AM, Maiorana NV, Marceglia S, Okun MS, Oliveri S, Ostrem JL, Scelzo E, Schnitzler A, Starr PA, Temel Y, Timmermann L, Tinkhauser G, Visser-Vandewalle V, Volkmann J, Priori A.   +26 more
europepmc   +1 more source

Nonparametric estimation of equity return distribution from index options [PDF]

I estimate a return distribution of an equity index from equity index option prices. I evaluate nonparametrically the option price function and a state price density at each 1-year return.
Yongjin Kim
core  

Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin

Molecular Oncology, EarlyView.
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla, Jan Kosla, Magdalena Prechova, Lukas Frick, Patricia Bortel, Yasmin Borutzki, Andrea Bileck, Christopher Gerner, Samuel M. Meier‐Menches, Selma Osmanagic‐Myers, Martin Gregor   +10 more
wiley   +1 more source